(Q42635935)

English

An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancer

scientific article published on December 2013

In more languages
default values for all languages
No label defined

No description defined

Statements

An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancer (English)
0 references
0 references
Giorgio V Scagliotti
Joachim von Pawel
Anders Mellemgaard
Pilar Lianes-Barragán
Rodrigo Ruiz-Soto
Thierry Lechevalier

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit